Angina Pectoris clinical trials

The registry lists 453 studies for Angina Pectoris across more than 10 countries. 67 are recruiting or about to start. 156 of them are mainly about Angina Pectoris (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 4 narrower conditions too, such as Angina, Stable: 1,067 studies, 168 open.

Get an email when these change. Save the Angina Pectoris studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 231
Status unknown: 83
Recruiting: 46
Terminated: 31
Active, not recruiting: 23
Not yet recruiting: 16

Phase

Phase 4: 58
Phase 2: 52
Phase 3: 40
Phase 1: 19
Early Phase 1: 1

Where

United States: 113
United Kingdom: 58
Denmark: 32
Germany: 31
Netherlands: 28
China: 27

Who runs them

CardioDx (11) · National Heart, Lung, and Blood Institute (NHLBI) (9) · Imperial College London (8) · Aarhus University Hospital Skejby (8) · University of Edinburgh (7) · Gilead Sciences (7) · Abbott Medical Devices (6) · China Academy of Chinese Medical Sciences (5)

What is being tested here

Drugs under test in Angina Pectoris studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Encoberminogene rezmadenovec	1	0	2
Amlodipine	1	1	2
Nebivolol	1	1	2
Bexagliflozin	1	0	1
Metoprolol	1	0	1
T89	1	1	1
Ranolazine	0	5	14
Aspirin	0	1	5
Nitroglycerin	0	0	5
Ivabradine	0	1	4

Drug classes tested here Beta blockers 3 open · Calcium channel blockers 2 open · Statins 9 · P2Y12 inhibitors 4

Coming up

5phase 3 studies under way

25studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Dec 2026Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina · Phase 3 · Tasly Pharmaceuticals, Inc.
Dec 2026Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries · Phase 3 · Stanford University
Nov 2026"Erectile Function After PCI in MI and Non-MI Patients" · Kırıkkale University
Nov 2026Inorganic Nitrate as a Treatment for ANOCA: NO-ANOCA · University of Virginia
Dec 2026Non-invasive Diagnosis of Coronary Microvascular Disease: Pilot Study · University of Leicester
Dec 2026Development of a Novel Risk Prediction Tool for Emergency Department Patients Symptoms of Coronary Artery Disease · University of Calgary
Dec 2026REGistry of Long-term AnTithrombotic TherApy-1 · National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Dec 2026SIROOP Registry - a Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated with SIROlimus or Paclitaxel Eluting Balloon Catheters · Luzerner Kantonsspital
Jan 2027Multivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Disease and aNgina · Imperial College London
Feb 2027Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System · Biotronik AG

Who these studies take

Of the 46 Angina Pectoris studies recruiting now, 35 (76%) set no upper age limit and 1 (2%) stop at 75 or younger. 3 (7%) take children under 18. 3 (7%) are for women only and 1 (2%) for men only; 4 (9%) take healthy volunteers.

Recruiting studies that take each age, of 46
Age	Women	Men
10	3 (7%)	3 (7%)
18	41 (89%)	39 (85%)
30	43 (93%)	42 (91%)
40	43 (93%)	42 (91%)
50	44 (96%)	42 (91%)
65	45 (98%)	43 (93%)
75	45 (98%)	43 (93%)
85	44 (96%)	41 (89%)

Across all 453 studies, recruiting or not: 11% stop at 75 or younger and 2% at 65; 11% take children; 3% are for women only and 2% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Angina Pectoris studies take

Of 72 interventional studies with no phase under Angina Pectoris, half reached primary completion within 43 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	43 mo18–64 · 72 studies	—	43 mo18–64 · 60 studies
Observational	33 mo19–56 · 67 studies	29 mo20–40 · 24 studies	36 mo18–86 · 43 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Inorganic Nitrate as a Treatment for ANOCA: NO-ANOCANov 9, 2026NCT06948201

Results posted1

Benidipine in Hypertensive and/or Chronic Coronary Syndrome PatientsNov 4, 2026NCT06808321

Studies

Recruiting first, then most recently updated. Showing 50 of 453. Browse all 453 → or search them.